Peptides for Health Benefits 2019 Volume 2

In recent years, peptides have received increased interest from the pharmaceutical industry. The high potency, specificity, and safety profile are the main strengths of bioactive peptides as new and promising therapies that may fill the gap between small molecules and protein drugs. These positive a...

Full description

Saved in:
Bibliographic Details
Other Authors: Hernández-Ledesma, Blanca (Editor), Martínez-Villaluenga, Cristina (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
Subjects:
pig
MDA
AMD
CNV
n/a
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_68680
005 20210501
003 oapen
006 m o d
007 cr|mn|---annan
008 20210501s2020 xx |||||o ||| 0|eng d
020 |a books978-3-03936-085-7 
020 |a 9783039360840 
020 |a 9783039360857 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-03936-085-7  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a GP  |2 bicssc 
072 7 |a PS  |2 bicssc 
100 1 |a Hernández-Ledesma, Blanca  |4 edt 
700 1 |a Martínez-Villaluenga, Cristina  |4 edt 
700 1 |a Hernández-Ledesma, Blanca  |4 oth 
700 1 |a Martínez-Villaluenga, Cristina  |4 oth 
245 1 0 |a Peptides for Health Benefits 2019  |b Volume 2 
260 |a Basel, Switzerland  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (342 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a In recent years, peptides have received increased interest from the pharmaceutical industry. The high potency, specificity, and safety profile are the main strengths of bioactive peptides as new and promising therapies that may fill the gap between small molecules and protein drugs. These positive attributes have renewed interest in the discovery, optimization, and development of peptides as pharmacological therapy. Among bioactive peptides, those released from food sources have acquired importance as nutraceutical and active components in functional foods because they possess regulatory functions that can lead to health benefits. This Special Issue covers a selection of recent research papers and reviews in the field of bioactive peptides. It covers all aspects of peptide research in relation to health promotion. In particular, it emphasizes current knowledge and research trends concerning bioactive peptides, including identification and quantification of peptides from new sources, methods for their production and purification, structure-function relationships, mechanisms of action, in vitro and in vivo assays for the evaluation of their bioactivity, physiological evidence to support health benefits, and peptide stability and bioavailability. Papers regarding the development of new drugs, functional foods, or nutraceuticals based on bioactive peptides were also considered. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Biology, life sciences  |2 bicssc 
653 |a antihypertensive peptides 
653 |a functional food 
653 |a food-derived 
653 |a fermentation 
653 |a Chlorella sorokiniana 
653 |a in silico 
653 |a BIOPEP-UWM database 
653 |a proteomics 
653 |a bioactive peptides 
653 |a nano liquid chromatography tandem mass spectrometry (nanoLC-nanoESI MS/MS) 
653 |a apolipoprotein E 
653 |a amyloid fibrils 
653 |a Alzheimer's disease 
653 |a Αβ oligomer 
653 |a amyloid 
653 |a Aβ peptide 
653 |a glioma 
653 |a platelets 
653 |a antiproliferative assay 
653 |a conjugation 
653 |a docetaxel 
653 |a doxorubicin 
653 |a extra domain B 
653 |a fibronectin 
653 |a Fmoc/tBu 
653 |a peptide-drug conjugate 
653 |a prostate cancer 
653 |a solid-phase synthesis 
653 |a targeting 
653 |a acrylamide 
653 |a enteric nervous system 
653 |a galanin 
653 |a pig 
653 |a stomach 
653 |a formyl peptide receptors 
653 |a ligands 
653 |a diseases 
653 |a polymicrobial biofilms 
653 |a intragenic antimicrobial peptide 
653 |a Hs02 
653 |a Pseudomonas aeruginosa 
653 |a Staphylococcus aureus 
653 |a osteostatin 
653 |a arthritis 
653 |a inflammation 
653 |a immune response 
653 |a cartilage destruction 
653 |a bone erosion 
653 |a collagen 
653 |a hydrolysis 
653 |a enzyme 
653 |a molecular weight 
653 |a sheepskin 
653 |a NF-κB 
653 |a dry-cured pork ham 
653 |a angiotensin I converting enzyme 
653 |a endothelial dysfunction 
653 |a molecular blind docking 
653 |a Lactoferricin B (Lfcin B) 
653 |a Histatin-5 
653 |a antimicrobial peptides (AMPs) 
653 |a antifungal activity 
653 |a proteome microarray 
653 |a synergy 
653 |a temporin 
653 |a MRSA 
653 |a antimicrobial peptide 
653 |a human keratinocytes 
653 |a pseudin-2 
653 |a antisepsis, peptide antibiotics 
653 |a neurotensin 
653 |a asthma 
653 |a T cells 
653 |a In situ tetramer staining 
653 |a MHC tetramer 
653 |a antigen-specific 
653 |a confocal microscopy 
653 |a fresh tissue 
653 |a velvet antler 
653 |a alcalase hydrolysate 
653 |a antioxidant peptide 
653 |a protection ability 
653 |a oxidative stress 
653 |a Crassostrea angulata 
653 |a pidotimod 
653 |a CXCR3 
653 |a monocyte 
653 |a migration 
653 |a PI3K/Akt pathway 
653 |a T cell 
653 |a immunomodulant 
653 |a host defense peptides 
653 |a membrane activity 
653 |a copper 
653 |a piscidins 
653 |a Clostridioides difficile 
653 |a prolactin-releasing peptide 
653 |a GPR10 
653 |a RF-amide peptides 
653 |a food intake regulation 
653 |a energy expenditure 
653 |a neuroprotection 
653 |a signaling 
653 |a gender differences 
653 |a dyslipidemia 
653 |a obesity 
653 |a hyperglycemia 
653 |a pulmonary emphysema 
653 |a endothelial progenitor cells 
653 |a angiogenic precursor cells 
653 |a pegylated glucagon-like peptide 1 
653 |a and endothelial regeneration 
653 |a miiuy croaker (Miichthys miiuy) 
653 |a swim bladder 
653 |a FPYLRH 
653 |a antioxidant activity 
653 |a cytoprotective effect 
653 |a antimicrobial peptides 
653 |a antimicrobial resistance 
653 |a AMP identification and design 
653 |a biosynthesis 
653 |a mode of action 
653 |a physico-chemical properties 
653 |a therapeutic potential 
653 |a insects 
653 |a Cecropins 
653 |a Cec-analogs 
653 |a MDR infectious diseases 
653 |a airway inflammation 
653 |a non-atopic asthma 
653 |a hybrid peptide 
653 |a pro-inflammatory cytokines 
653 |a sPLA2 
653 |a MDA 
653 |a database 
653 |a proteolysis 
653 |a SMILES code 
653 |a foods 
653 |a nutrition 
653 |a chronic diseases 
653 |a nutraceuticals 
653 |a peptide vaccine 
653 |a immune checkpoint inhibitor 
653 |a humanized mouse 
653 |a cancer antigen 
653 |a immune suppression 
653 |a vasoactive intestinal peptide 
653 |a VPAC1 receptor 
653 |a VPAC2 receptor 
653 |a rheumatic diseases 
653 |a inflammatory bowel disease 
653 |a central nervous system diseases 
653 |a type 1 diabetes 
653 |a Sjögren's syndrome 
653 |a biomarkers 
653 |a human antimicrobial peptides 
653 |a defensins 
653 |a cathelicidins 
653 |a anti-inflammatory 
653 |a pro-inflammatory 
653 |a peptide 
653 |a combinatorial library 
653 |a library design 
653 |a screening 
653 |a mutagenesis 
653 |a prolyl-hydroxyproline (Pro-Hyp) 
653 |a hydroxyprolyl-glycine (Hyp-Gly) 
653 |a collagen peptide 
653 |a fibroblasts 
653 |a fetal bovine serum (FBS) 
653 |a AMD 
653 |a CNV 
653 |a VEGFR1 
653 |a multimeric peptides 
653 |a oral delivery 
653 |a colorectal cancer 
653 |a cancer stem cells 
653 |a chemoprevention 
653 |a bioactive peptide 
653 |a lunasin 
653 |a ACE-inhibitory activity 
653 |a whey peptides 
653 |a molecular docking 
653 |a hypertension 
653 |a antibiotic resistance 
653 |a cystic fibrosis 
653 |a cryptides 
653 |a anti-biofilm peptides 
653 |a synergistic effects 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/2444  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/68680  |7 0  |z DOAB: description of the publication